CORONAVIRUS DIAGNOSTICS MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: BYR-78772 | Health Care
Historical data: 2017 - 2023
Forecast period: 2025 - 2031
Quantitative units: Revenue in USD million and CAGR from 2025 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Coronavirus Diagnostics Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL CORONAVIRUS DIAGNOSTICS MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL CORONAVIRUS DIAGNOSTICS MARKET
7.1 GLOBAL CORONAVIRUS DIAGNOSTICS MARKET SIZE AND SHARE (2017 - 2031) (USD MILLION)
8.1 GLOBAL CORONAVIRUS DIAGNOSTICS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
8.2 GLOBAL CORONAVIRUS DIAGNOSTICS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
9.1 GLOBAL CORONAVIRUS DIAGNOSTICS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
9.2 GLOBAL CORONAVIRUS DIAGNOSTICS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
10.1 GLOBAL CORONAVIRUS DIAGNOSTICS MARKET SIZE AND SHARE BY REGION (2017 - 2023) (USD MILLION)
10.2 GLOBAL CORONAVIRUS DIAGNOSTICS MARKET SIZE AND SHARE BY REGION (2025 - 2031) (USD MILLION)
11.1 NORTH AMERICA CORONAVIRUS DIAGNOSTICS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
11.2 NORTH AMERICA CORONAVIRUS DIAGNOSTICS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
11.3 NORTH AMERICA CORONAVIRUS DIAGNOSTICS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
11.4 NORTH AMERICA CORONAVIRUS DIAGNOSTICS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
11.5 NORTH AMERICA CORONAVIRUS DIAGNOSTICS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
11.6 NORTH AMERICA CORONAVIRUS DIAGNOSTICS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
12.1 EUROPE CORONAVIRUS DIAGNOSTICS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
12.2 EUROPE CORONAVIRUS DIAGNOSTICS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
12.3 EUROPE CORONAVIRUS DIAGNOSTICS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
12.4 EUROPE CORONAVIRUS DIAGNOSTICS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
12.5 EUROPE CORONAVIRUS DIAGNOSTICS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
12.6 EUROPE CORONAVIRUS DIAGNOSTICS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
13.1 ASIA PACIFIC CORONAVIRUS DIAGNOSTICS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
13.2 ASIA PACIFIC CORONAVIRUS DIAGNOSTICS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
13.3 ASIA PACIFIC CORONAVIRUS DIAGNOSTICS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
13.4 ASIA PACIFIC CORONAVIRUS DIAGNOSTICS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
13.5 ASIA PACIFIC CORONAVIRUS DIAGNOSTICS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
13.6 ASIA PACIFIC CORONAVIRUS DIAGNOSTICS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
14.1 LATIN AMERICA CORONAVIRUS DIAGNOSTICS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)/p>
14.2 LATIN AMERICA CORONAVIRUS DIAGNOSTICS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
14.3 LATIN AMERICA CORONAVIRUS DIAGNOSTICS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
14.4 LATIN AMERICA CORONAVIRUS DIAGNOSTICS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
14.5 LATIN AMERICA CORONAVIRUS DIAGNOSTICS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
14.6 LATIN AMERICA CORONAVIRUS DIAGNOSTICS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA CORONAVIRUS DIAGNOSTICS MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA CORONAVIRUS DIAGNOSTICS MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA CORONAVIRUS DIAGNOSTICS MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA CORONAVIRUS DIAGNOSTICS MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA CORONAVIRUS DIAGNOSTICS MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA CORONAVIRUS DIAGNOSTICS MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031)< (USD MILLION)/p>
16.1 F. Hoffmann-La Roche AG (Switzerland)
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Bio-Rad Laboratories Inc. (United States)
16.3 Beckman Coulter Inc. (United States)
16.4 Becton, Dickinson, and Company (United States)
16.5 Lonza Group AG (Switzerland)
16.6 Hologic, Inc. (United States)
16.7 QIAGEN (Germany)
16.8 GlaxoSmithKline Biologicals SA (Belgium)
16.9 Abbott Laboratories (United States)
16.10 Perkin Elmer, Inc. (United States)
16.11 Neuberg Diagnostics (India)
16.12 1drop Inc. (Switzerland)
16.13 Veredus Laboratories (Hong Kong)
16.14 ADT Biotech (Malaysia)
16.15 Quest Diagnostics (United States)
16.16 LabCorp (United States)
16.17 altona Diagnostics GmbH (Germany)
16.18 bioMerieux SA (France)
16.19 Mylab Discovery Solutions Pvt Ltd. (India)
16.20 Aldatu Biosciences (United States)
16.21 Quidel Corporation (United States)
16.22 Luminex Corporation (United States)
16.23 Cepheid Inc. (United States)
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
By TypeMolecular
Serology
Antigen-Based
By Product Used
Instruments
Reagents & Kits
By Infection Type
HCoV-229E
HCoV-OC43
SARS-CoV
HKU1-CoV
MERS-CoV
By End-Users
Hospitals
Public Health Labs
Private or Commercial Labs
Physician Labs
Diagnostic Centers and Clinics
Research Institutes
Others
By Sample Type
Nasopharyngeal (NP) Swab
Oropharyngeal (OP) Swab
Nasal Swab
By Mode of Diagnosis
Point-of-Care (POC)
Non-Point-of-Care (Non-PoC)
Companies
F. Hoffmann-La Roche AG (Switzerland)
Bio-Rad Laboratories Inc. (United States)
Beckman Coulter Inc. (United States)
Becton, Dickinson, and Company (United States)
Lonza Group AG (Switzerland)
Hologic, Inc. (United States)
QIAGEN (Germany)
GlaxoSmithKline Biologicals SA (Belgium)
Abbott Laboratories (United States)
Perkin Elmer, Inc. (United States)
Neuberg Diagnostics (India)
1drop Inc. (Switzerland)
Veredus Laboratories (Hong Kong)
ADT Biotech (Malaysia)
Quest Diagnostics (United States)
LabCorp (United States)
altona Diagnostics GmbH (Germany)
bioMerieux SA (France)
Mylab Discovery Solutions Pvt Ltd. (India)
Aldatu Biosciences (United States)
Quidel Corporation (United States)
Luminex Corporation (United States)
Cepheid Inc. (United States)
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.